510(k) Report

FDA applicant

DiaSorin, Inc.

Stillwater, MN97 decisions1990–202616 recalls

FDA records 97 decisions for DiaSorin, Inc. (Stillwater, MN) from 1990 to 2026: 73 510(k) clearances, 1 De Novo grant and 23 original PMA approvals. Most are in product codes LOL (Hepatitis A Test (Antibody And Igm Antibody)) and LOM (Test, Hepatitis B (B Antigen, B Surface…). Since 2016 its 510(k)s took a median of 89 days from receipt to decision, against 90 for FDA’s reviews in the same codes and years. Its devices cite 82 predicates, 40 of them its own earlier devices. 16 recalls are linked to its devices.

FDA’s records also spell it “Diasorin”, “Diasorin S.P.A”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, microbiology panel, where it files most

How often FDA has decided DiaSorin, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2007: 32008: 52009: 22011: 12012: 22013: 102014: 22015: 22016: 42017: 32018: 32019: 42020: 102021: 42022: 32023: 12024: 12025: 12026 (partial year): 2
2007high 10 (2013) · low 0 (2010)2026

2026 so far, outlined.

Recalls per year

1in 2024

2008: 22010: 12015: 12020: 22023: 12024: 1
2007high 2 (2008) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — DiaSorin, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like DiaSorin, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “DiaSorin”

FDA records each applicant name separately; these may or may not be the same firm.